Thermo Fisher (TMO) Acquires One Lambda for $925M
Tweet
Share
E-mail
Get Alerts TMO Hot Sheet
Price: $675.00 -0.5%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 0.3%
Revenue Growth %: +7.5%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 0.3%
Revenue Growth %: +7.5%
Join SI Premium – FREE
Thermo Fisher Scientific Inc. (NYSE: TMO) signed a definitive agreement to acquire One Lambda, the leader in transplant diagnostics, for $925 million in cash.
The purchase price includes the cost of a three-year retention program established by One Lambda for the benefit of key employees, amounts payable to certain shareholders for noncompetition agreements, and a one-year earn-out provision based on the achievement of certain financial targets.
The transaction, which is expected to be completed in the fourth quarter of 2012, is expected to be immediately accretive upon close and add $0.09 to $0.11 to Thermo Fisher’s 2013 adjusted earnings per share.
The purchase price includes the cost of a three-year retention program established by One Lambda for the benefit of key employees, amounts payable to certain shareholders for noncompetition agreements, and a one-year earn-out provision based on the achievement of certain financial targets.
The transaction, which is expected to be completed in the fourth quarter of 2012, is expected to be immediately accretive upon close and add $0.09 to $0.11 to Thermo Fisher’s 2013 adjusted earnings per share.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA raises AMD target to $720, sees server CPU TAM tripling to $211B by 2030
- KLX Energy narrows Q3 2026 revenue guidance, completes rights offering
- MVB Bank partners with DingoBlu on mobile banking platform
Create E-mail Alert Related Categories
Hot M&A, Mergers and AcquisitionsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
